The pooled data from 8 different studies yielded an average median OS of 32 weeks. HC is pointing out that those 8 studies of Avastin individually ranged from 26.0 weeks to 45.7 weeks of median OS. Still a good chance for VB-111 to beat, but on-balance, only a few investors are getting ahead of the results here.
Market Data 
Markets 
AI
